Evidence map›Paper›PMID 35354887›Full record

ArticleScientific reports2022

The Pseudomonas syringae type III effector HopG1 triggers necrotic cell death that is attenuated by AtNHR2B.

Catalina Rodríguez-Puerto, Rupak Chakraborty, Raksha Singh, Perla Rocha-Loyola, Clemencia M Rojas

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. TheFrontiers in microbiology · 2023
    Article
  3. Fungal Effectoromics: A World in Constant Evolution.International journal of molecular sciences · 2022
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Catalina Rodríguez-Puerto *Department of Entomology and Plant Pathology, University of Arkansas, Fayetteville, AR, 72703, USA.
Rupak Chakraborty *Department of Entomology and Plant Pathology, University of Arkansas, Fayetteville, AR, 72703, USA.
Raksha SinghDepartment of Entomology and Plant Pathology, University of Arkansas, Fayetteville, AR, 72703, USA.
Perla Rocha-LoyolaDepartment of Entomology and Plant Pathology, University of Arkansas, Fayetteville, AR, 72703, USA.
Clemencia M RojasDepartment of Entomology and Plant Pathology, University of Arkansas, Fayetteville, AR, 72703, USA. cr022@uark.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plant pathogenic bacterium Pseudomonas syringae pv. tomato DC3000 (Pst DC3000) has become a paradigm to investigate plant-bacteria interactions due to its ability to cause disease in the model plant Arabidopsis thaliana. Pst DC3000 uses the type III secretion system to deliver type III secreted effectors (T3SEs) directly into the plant cytoplasm. Pst DC3000 T3SEs contribute to pathogenicity by suppressing plant defense responses and targeting plant's physiological processes. Although the complete repertoire of effectors encoded in the Pst DC3000 genome have been identified, the specific function for most of them remains to be elucidated. Among those effectors, the mitochondrial-localized T3E HopG1, suppresses plant defense responses and promotes the development of disease symptoms. Here, we show that HopG1 triggers necrotic cell death that enables the growth of adapted and non-adapted pathogens. We further showed that HopG1 interacts with the plant immunity-related protein AtNHR2B and that AtNHR2B attenuates HopG1- virulence functions. These results highlight the importance of HopG1 as a multi-faceted protein and uncover its interplay with AtNHR2B.

Indexed as

ArabidopsisPseudomonas syringaeBacterial ProteinsCell DeathPlant DiseasesBacterial Proteins

Identifiers

PMID35354887
PMCPMC8967837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.